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Allostatic load (AL) is a measure of cumulative “wear and tear” on the body resulting 
from exposure to chronic stress. Recently, a potential link between AL and poor birth 
outcomes was proposed, although it is unknown whether AL can be measured in a 
meaningful way during pregnancy. To determine this, an AL index was created using 
data from the National Health and Nutrition Examination Survey (NHANES), 1999-
2006. The distribution of AL scores were significantly different in pregnant and non-
pregnant women (p<0.01). AL scores were associated with race, age, income, and 
education level in the sample of non-pregnant women, but similar associations were 
not seen in pregnant women. Overall, the results of this study suggest that AL does 
not have the same attributes in pregnant women as it does in non-pregnant women. 
However, the findings suggest directions for future study of AL as a risk factor for 
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Chapter 1: Introduction 
 
Allostatic load (AL) is considered to be a measure of the cumulative “wear and 
tear” on the body that results from exposure to chronic psychosocial stress (McEwan and 
Stellar, 1993). Studies have suggested an association between AL and a variety of health 
conditions. Recently, a potential link between AL and adverse birth outcomes has been 
proposed in exploratory articles, although this relationship has been challenging to 
investigate because it is unknown whether AL can be measured in a meaningful way 
during pregnancy (Anderson, 2008; Shannon et al., 2007). Pregnant women are generally 
excluded from studies of AL because there is concern that the changing levels of AL-
related biomarkers during pregnancy do not reflect a woman’s true AL (Seeman et al., 
2008). Indeed, pregnancy changes the levels of many AL-related biomarkers, including 
blood pressure, heart rate, cholesterol, and metabolic and inflammatory factors (Merck 
Manual, 2007). As a result, it is challenging to differentiate the effects of chronic stress 
on these biomarkers from the changes that occur as a normal part of pregnancy.  
To our knowledge, this study is the first to determine the usefulness of measuring 
AL during pregnancy. Although the levels of AL-related biomarkers during pregnancy 
are different than their levels before and after pregnancy, the relative ranking of AL 
scores in pregnant women could provide meaningful information about the women’s 
health risks related to chronic stress. A valid measure of AL could help identify pregnant 
women at risk of poor birth outcomes, such as low birthweight and premature birth, who 




differences in birth outcomes among women of different race/ethnic backgrounds and 




Chapter 2: Background and Literature Review 
 
Chronic stress and risk of adverse birth outcomes 
A variety of clinical and behavioral risk factors have been linked to an increased 
risk of adverse birth outcomes such as low birthweight and premature birth. The maternal 
risk factors most consistently associated with these outcomes include certain infections, a 
shortened cervix, a previous preterm birth, maternal age, underweight or overweight 
during pregnancy, diabetes mellitus, smoking or exposure to secondhand smoke, alcohol 
or drug abuse, multi-parity, and inadequate prenatal care (NICHD 2010; McCowan et al., 
2009; March of Dimes, 2008; Ashdown-Lambert, 2005; Bibby & Stewart, 2004). 
However, established risk factors account for only a fraction of all poor birth outcomes 
(NICHD, 2010). Thus, a large proportion of low birthweight and premature infants are 
born to mothers who are not considered clinically to be “high-risk.” Identifying other 
factors that may help explain these cases is an important challenge in maternal and child 
health. 
Maternal stress has been studied as a potential contributor to adverse birth 
outcomes (Vrekoussis et al., 2010). Traditionally, stress has been considered in terms of 
acute events that activate the body’s “fight-or-flight” response. Acute stress that occurs 
during pregnancy, for example exposure to a traumatic event such as the terrorist attacks 
on September  11, 2001, has been associated with increased incidence of both low 
birthweight and preterm birth in several studies (Ohlsson et al., 2010; Lauderdale, 2006; 
Smits et al., 2006). However, chronic stress before and during pregnancy may be an even 




(Vrekoussis et al., 2010). Chronic stressors are repetitive events or ongoing conditions 
that activate the physiologic “fight-or-flight” response but are not quickly resolved 
(Latendresse, 2009). Chronic stressors such as racial discrimination have been widely 
identified as a risk factors for adverse birth outcomes, including preterm birth, low 
birthweight, and miscarriage (Vrekoussis et al., 2010; Latendresse, 2009; Parker & 
Douglas, 2009; Hobel et al. 2008) 
 
Disparities in birth outcomes  
Disparities in birth outcomes among women of different race/ethnic backgrounds 
have been recognized for decades (Blumenshine et al., 2010; Parker Dominguez, 2008). 
These disparities are most pronounced in non-Hispanic Blacks compared to non-Hispanic 
Whites (Miranda et al., 2009). For example, in 2009 non-Hispanic Black mothers had 
more than 1.5 times the rate of preterm births and almost twice the rate of low 
birthweight infants than non-Hispanic White or Hispanic mothers in the United States 
(Martin et al., 2011). These disparities have been relatively constant over the past several 
decades and are correlated with socioeconomic status (SES), social factors such as 
marital status,  and adverse environmental conditions such as exposure to environmental 
tobacco smoke (Blumenshine et al., 2010; Miranda et al., 2009). Perceived racial 
discrimination in various settings has also been associated with an increased risk of 
preterm birth and low birthweight in Black mothers (Giurgescu et al., 2011; Rankin et al., 
2011; Collins et al., 2004). 
Disparities in birth outcomes are also correlated with SES independent of race. 




births or babies with low birthweight than are women of higher SES (Simmons et al., 
2010; Bibby & Stewart, 2004). This link may be explained, in part, by differences in 
access to prenatal care and other services, and prevalence of behavioral risk factors such 
as cigarette smoking (Blumenshine et al., 2010; Villabi et al., 2007). Recent studies show 
that chronic stress is another factor contributing to racial and SES-related disparities in 
preterm birth and low birthweight (Parker Dominguez, 2008). In addition to individual-
level SES, factors related to neighborhood-level SES have also been associated with risk 
of having a low birthweight or preterm infant (Metcalfe et al., 2011; Vinikoor-Imler et 
al., 2011). These neighborhood factors include median income, physical incivilities, 
crime rates, unemployment rates, and racial segregation (Metcalfe et al., 2011). 
 
The weathering hypothesis 
Although chronic stress appears to contribute to adverse birth outcomes, the 
factors that mediate this relationship have not been fully elucidated. To help explain 
racial and SES-related health disparities in birth outcomes, Geronimus (1992) proposed 
the concept of “weathering.” This hypothesis suggests that the elevated risk of adverse 
birth outcomes among Black mothers compared to White mothers is due, in part, to 
premature aging of the body’s physiologic systems. These differences affect multiple 
dimensions of health, including reproduction. 
Among White women, there is little evidence of weathering (Geronimus et al., 
1996). However, among Black women, the risk of having an infant with low birthweight 
increases with maternal age. The gap in risk of adverse birth outcomes between Black 




are about twice as likely as White mothers of the same age to have a low birthweight or 
very low birthweight infant. However, by age 34, Black mothers are about three times as 
likely to have a low birthweight infant and more than five times as likely to have a very 
low birthweight infants than White mothers of the same age (Geronimus et al., 1996). 
These disparities are especially pronounced among Black and White women of lower 
SES.  
Geronimus (1992) speculated that Black women experience faster physiologic 
aging than White women for many reasons, among them increased stress due to family, 
work, and social obligations. Thus weathering could help explain the observed 
association between exposure to chronic stress and disparities in birth outcomes.  
 
Allostatis and allostatic load 
The biological mechanisms that underlie weathering remain unclear, although the 
concept of allostatic load (AL) has been proposed as one such mechanism (Geronimus et 
al., 2006). The foundation of AL is allostasis, or “stability through change” (Sterling & 
Eyer, 1988). Unlike homeostasis, which focuses on a predetermined set-point or a narrow 
range of physiologic functioning in which health can be maintained, allostasis suggests 
that there are optimal operating ranges and that physiologic systems work together in 
complex, nonlinear networks to maintain health (Carlson & Chamberlain, 2005). 
Allostasis emphasizes the need for dynamic, ongoing adjustments to adapt to external 
demands (Seeman et al., 1997). An organism achieves allostasis by matching the activity 





AL was first introduced by McEwan and Stellar (1993). It is traditionally defined 
as a measure of the wear and tear the body experiences as it attempts to adapt to life’s 
demands (Seeman et al., 2001). Systems involved in reacting to and coping with stress 
must be turned on at the appropriate times and then turned off when they are no longer 
needed. If these systems are turned on for too long or too often, or alternately if they 
cannot be mobilized adequately when needed, the resulting dysregulation contributes to 
wear and tear on the body (McEwan, 1998). Repeated cycles of allostasis in response to 
chronic stress can ultimately cause physiologic systems to operate inefficiently or outside 
their normal ranges. Consequently, AL tends to increase with age (Crimmins et al., 
2003). 
McEwan and Seeman (1999) expanded the definition of AL to include “a cascade 
of cause and effect” that begins with the release of primary mediators, specifically 
catecholamines and hormones such as cortisol, which comprise the body’s “fight-or-
flight” response to perceived stress. The release of these chemicals leads to changes in 
secondary mediators such as increased blood pressure and heart rate, which are measures 
of cardiovascular function, and changes in the levels of immune system factors such as 
C-reactive protein. It is these secondary mediators that are typically included in indexes 
of allostatic load, as they are most often measured clinically (Juster et al., 2010). It has 
been suggested that repeated and excessive activation of these secondary mediators can 
lead to tertiary outcomes such as chronic disease and adverse birth outcomes 
(Karlamangla et al., 2002).  
Much of the current knowledge about the association of AL with particular health 




2006; Karlamangla et al., 2002; Seeman et al., 2001; Seeman et al., 1997). These 
longitudinal studies, which followed a cohort of older American adults, found that higher 
AL scores were associated with poorer cognitive and physical performance (Karlamangla 
et al., 2002; Seeman et al., 2001; Seeman et al., 1997), increased all-cause mortality 
(Geronimus et al., 2006; Karlamangla et al., 2006; Karlamangla et al., 2002; Seeman et 
al., 2001), and elevated risk of cardiovascular events (Karlamangla et al., 2002). More 
recent research with other populations has led to similar findings; Borrell et al. (2010) 
found that AL was associated with an elevated risk of all-cause mortality in NHANES III 
participants. Mattei et al. (2010) discovered that AL was associated with several chronic 
diseases, including hypertension, diabetes, cardiovascular disease, and arthritis in 
participants of the Boston Puerto Rico Health Study. 
 
Allostatic load and health disparities 
AL appears to accumulate differently in people of different races, making it a 
promising mechanism to help explain racial health disparities. In a seminal study of AL 
and race, Geronimus et al. (2006) found that Blacks had higher AL scores than Whites at 
all ages, and the difference increased with age. Additionally, Black women overall had 
higher AL scores than Black men. The authors hypothesize that these differences may be 
a result of increased exposure to chronic stressors among Black women compared to 
other groups, stressors which require more “sustained and high-effort coping” that 
increases wear and tear on the body over time (Geronimus et al., 2006, p. 831).  Chyu and 




based sample of adults in Texas also found that Black individuals had higher AL scores 
overall compared to people of other races.   
Few studies have analyzed AL differences in people of  race/ethnic backgrounds 
other than non-Hispanic Black and non-Hispanic White; however, several studies have 
shown that recent Mexican immigrants tend to have lower AL scores than immigrants 
who had been in the United States for longer or than U.S.-born Mexicans, Blacks, or 
Whites (Peek et al., 2010; Kaestner et al., 2010). Another recent study found that chronic 
work, financial, and caregiving stressors were associated with higher AL scores in 
middle-aged Mexican American women (Gallo et al., 2011). 
Although studies to date have been limited, AL has been inversely correlated with 
SES independent of race (Gustafsson et al., 2011; Hawkley et al., 2011). Thus AL may 
also help explain SES-related health disparities. Individual-level SES factors that have 
been associated with higher AL scores have included lower household income and 
individual education levels (Chyu & Upchurch, 2011; Gustafsson et al., 2011; Seeman et 
al., 2008; Sabbah et al., 2008). Neighborhood-level SES factors associated with higher 
AL scores have included percentage of households with low education, percentage of 
households with low median income, percentage of households headed by only a female 
caregiver, and high unemployment rates (Bird et al., 2010; Merkin et al., 2009).  
 
Allostatic load and reproductive health 
Although AL has been associated with the risk of multiple health outcomes, only 




study found that higher AL scores in adulthood were associated with self-reported earlier 
age at menarche (Allsworth et al., 2005).  
Based on current knowledge of the effects of chronic stress during pregnancy, 
several exploratory articles  have proposed that AL could help explain adverse birth 
outcomes (Anderson, 2008; Shannon et al., 2007). In their review, Shannon et al. (2007) 
assert that growing evidence supports a relationship between maternal stress and adverse 
pregnancy outcomes, and that AL may help explain these outcomes in women without 
other identified risk factors. Anderson (2008) adds that patterns seen in failure to progress 
during labor may be consistent with the AL model. Although these papers raise 
interesting questions, no studies have yet been undertaken to assess the relationship of 
AL and birth outcomes. In part, these studies have not been attempted because measuring 
the effects of stress during pregnancy is complicated by the normal changes in various 
AL-related biomarkers that occur while a woman is pregnant (Shannon et al., 2007). For 
this reason, most studies of AL to date have excluded pregnant women.  
 
Public health significance 
As of 2009, about 12% of all infants born in the U.S. were preterm (<37 weeks 
gestation) and 8.2% were low birthweight (<2,500 grams) (Martin et al., 2011). Preterm 
birth is among the leading causes of infant death (CDC, 2011a; NICHD 2010). Preterm 
birth and low birthweight are associated with an increased risk of respiratory problems, 
infections, cerebral palsy, vision and hearing abnormalities, and developmental 
disabilities (CDC, 2011a; March of Dimes, 2008). Additionally, these adverse birth 




and related outcomes such as stroke, hypertension, and non-insulin dependent diabetes in 
adulthood (Barker et al., 2002). For these reasons, reducing preterm births and low 
birthweight are among the Healthy People 2020 objectives (Healthypeople.gov, 2011). 
Ultimately, finding a mechanism linking maternal chronic stress with risk of 
adverse birth outcomes could help identify more women at risk of having low birthweight 
or preterm infants. Determining whether AL can be measured in a meaningful way during 






Chapter 3: Research Questions and Specific Aims  
 
The overall goal of this project was to determine whether AL can be measured in 
a meaningful way in pregnant women. To accomplish this, the characteristics of AL were 
examined to determine whether they are similar in pregnant women and non-pregnant 
women.  
 
The six specific aims of this study were: 
 
Aim 1: Establish norms for the distribution of each of the ten AL-related biomarkers 
among pregnant and non-pregnant women in the study sample. 
 
Aim 2: Describe the levels of AL-related biomarkers at different stages of pregnancy, 
including by trimester and in early pregnancy (less than 5 months) vs. late pregnancy (5+ 
months). 
 
Aim 3: Determine whether results from the study sample are consistent with ranges of 
AL-related biomarkers reported in clinical data for normal pregnant women. 
 
Aim 4: Create an AL index and calculate AL scores in the sample of pregnant and non-
pregnant women. If it is meaningful to measure AL during pregnancy, the mean and 





Aim 5: Determine whether AL scores measured at different times during pregnancy are 
consistent with scores in pregnant women overall.  
 
Aim 6: Determine whether AL has attributes in pregnant women similar to those in non-
pregnant women. Specifically, examine AL with regard to race, age, education, and 





Chapter 4: Methods 
 
Data source and study population 
This study assessed the levels of ten AL-related biomarkers in a nationally 
representative sample of pregnant and non-pregnant women aged 15-44. The sample 
came from the National Health and Nutrition Examination Survey (NHANES), an 
ongoing nationwide study from the National Center for Health Statistics (NCHS). 
Participants in NHANES are selected and weighted to represent the civilian, non-
institutionalized U.S. population. 
The NHANES study has two major parts: an in-home interview and a physical 
examination conducted in a mobile examination center (MEC). In this study, data about 
participants’ demographic and socioeconomic characteristics, as well as medication use, 
came from the in-home interview. Laboratory test results and results of the physical 
examination came from the MEC. These data are freely available for download at 
http://www.cdc.gov/nchs/nhanes.htm. NHANES data are released in 2-year cycles. This 
study combined data from 1999-2006, an 8-year period (4 cycles) in which pregnant 
women were oversampled (Mirel et al., 2009). 
As recommended in the NHANES documentation (CDC, 2011b), the variable 
RIDEXPRG was used to identify pregnant women. This variable represents pregnancy 
status at the time of the physical examination at the MEC and incorporates both urine 











1 Pregnant at 
exam 
All participants with a positive urine pregnancy 
test AND all participants who reported being 
pregnant but had a negative urine pregnancy test. 
(The latter situation accounts for less than 1% of 
all women in the sample used in this study who 
were coded as RIDEXPRG=1.) 
2 Not pregnant at 
exam 
All participants who reported not being pregnant 
and who had a negative urine pregnancy test. 
3 Could not be 
determined 
All participants who were interviewed but not 
examined, and who therefore did not have a urine 
pregnancy test result. 
 
For the purposes of this study, women whose pregnancy status at exam was 
negative and who reported having given birth within the past year were not included in 
either the pregnant group or the non-pregnant group. These women were excluded 
because, although they are no longer pregnant, the levels of AL-related biomarkers are 
unlikely to return to non-pregnant levels soon after giving birth. The NHANES variable 
RHQ200, “Now breastfeeding a child?” was used to identify women who gave birth 
within the past year. Breastfeeding status was not of interest in this study; rather, this 
question was used because it is only asked of women who reported having had a live 
birth within one year of the survey. Women who answered either “yes” or “no” to this 
question were excluded from the sample, as either answer identifies the participant as 
having given birth within the past year.  
In addition to comparing the levels of AL-related biomarkers in pregnant and non-




trimester and in early vs. late pregnancy. Women in NHANES who reported being 
pregnant were asked to report the month of their pregnancy. This information was used to 
determine the trimester of pregnancy: 1st = 1, 2, or 3 months; 2nd = 4, 5, or 6 months; 3rd = 
7+ months. It was also used to define early pregnancy (less than 5 months) and late 
pregnancy (5+ months). Pregnant women who did not report their month of pregnancy 
but who reported having their last menstrual period less than 2 months prior were 
considered to be in their first trimester and in early pregnancy. Pregnant women who did 
not report their month of pregnancy and who did not have their last menstrual period 
within the past 2 months were not included in this analysis. 
Limiting the age range in this study to 15-44 years is consistent with the way the 
CDC reports natality data, including fertility rates and birth rates (Martin et al., 2011). 
Excluding women younger than 15 and older than 44 excluded only 6 pregnant women 
from the 8-year NHANES sample. Clearly, women outside this age range do not 
represent a significant proportion of all pregnant women, so restricting the ages to 15-44 
years does not impact generalizability of the results. 
A flow chart outlining how the samples of pregnant and non-pregnant women in 
this study were chosen from all NHANES participants is included in Appendix 1. 
 
Choosing AL-related biomarkers 
There is no single, “gold-standard” approach to operationalizing AL (Seeman et 
al., 2010). Juster et al. (2010) listed 25 biomarkers that have been used to create AL 
indices in previous studies. The biomarkers for this study were chosen from that list, 




biomarkers, including waist-to-hip ratio and body mass index, were excluded because 
they are unlikely to be meaningful for pregnant women. Glucose and insulin were 
excluded because they were measured only in fasting NHANES participants and 
therefore are available only in a small subset of NHANES participants. Additionally, 
fibrinogen was excluded because it was measured only in participants who were at least 
40 years old and was not measured after 2002.  
Of the remaining AL-related biomarkers, ten were included in each NHANES 
data cycle from 1999-2006 (Table 2). All of the biomarkers were measured as part of the 
physical and laboratory examination at the MEC. Because systolic and diastolic blood 
pressure were typically read several times over a period of minutes, these measures were 
averaged to create a single systolic and a single diastolic measurement for each 
participant. To be included in this study, each participant must have had values for at 





Table 2: AL-related biomarkers chosen for this study 









Protein involved in activating the complement 
system. Levels rise in response to 
inflammation.  
Albumin Metabolic LBXSAL 
(g/dL) 
Water-soluble protein that helps regulate 





Lipoprotein used in the production of 








AKA “good cholesterol;” a lipoprotein that 
transports cholesterol from tissues to the liver 
for removal. 
Creatinine Metabolic LBDSCRSI 
(µmol/L) 
A breakdown product of creatine phosphate in 





An index of average plasma glucose 





An amino acid synthesized from methionine; 























(30 sec.  
pulse * 2) 
The number of heartbeats that occur in a 60-
second period. 
 
Establishing normal ranges for each AL-related biomarker 
The major reason that AL is typically not measured during pregnancy is that the 




suggests that these levels change in predictable ways. A literature review was performed 
to determine the normal ranges of the various AL-related biomarkers during pregnancy. It 
was then determined whether the level of each biomarker in the NHANES sample fell 
within the published ranges. 
Studies undertaken to determine the reference ranges of specific biomarkers 
during pregnancy are relatively scarce and have varied methodology. Some studies report 
reference ranges for multiple biomarkers of interest, while others focus on a single 
biomarker. The following guidelines were developed to prioritize the available studies: 1) 
Reference ranges were reported from longitudinal studies, when available, of healthy 
pregnant women undertaken within the last two decades. 2)  Studies with reference 
ranges provided for the entire pregnancy were preferred; the ranges are often broken 
down by week or by trimester in these studies. 3) Although the definition of a “healthy” 
pregnancy varied among the studies, all of the articles must have described their criteria 
for determining a healthy pregnancy. 4) In rare instances in which more than one study 
was available that met these guidelines, the reference range from the study with the 
largest sample size was reported.  
In addition, clinical reference materials were used to identify the general trend or 
direction of change for each AL-related biomarker over the course of a pregnancy. (That 
is, whether the level of the biomarker increases, decreases, or fluctuates during 
pregnancy.) The mean level of each biomarker in the sample of pregnant women was 
then compared to the reference ranges established through previous studies and to the 





Creating the AL index and reporting AL in pregnant and non-pregnant women 
The AL index was created following the methods of several key AL studies 
(Seeman et al., 2008; Geronimus et al., 2006; Seeman et al., 2004; Seeman et al., 2001; 
Seeman et al., 1997). As in these studies, the current study used empirical cutoff points to 
establish “low-risk” and  “high-risk” values for each biomarker. Those participants in the 
high-risk quartile for each biomarker were given a score of 1 for that biomarker; the 
others were considered low-risk and given a score of 0. For most AL-related biomarkers, 
high-risk values represent the top 25% of the distribution. However, for albumin and 
HDL cholesterol, high-risk values are those in the bottom 25% of the distribution.  
The use of certain medications was taken into account when scoring several 
biomarkers, following Geronimus et al. (2006). Regardless of whether the value of total 
cholesterol and HDL cholesterol fell within the high-risk quartile, a participant was given 
a score of 1 for total and HDL cholesterol if she reported current use of medications to 
control cholesterol. Similarly, participants received a score of 1 for hemoglobin A1C if 
they reported current use of insulin or pills to lower blood sugar. Additionally, 
participants received a score of 1 for systolic and diastolic blood pressure if they reported 
current use of mediations to control blood pressure. 
The argument for taking medication use into account when scoring AL is that 
these participants are considered to be clinically high-risk for conditions related to 
particular AL-related biomarkers. The use of these medications suggests that the 
individuals are at high enough risk of cardiovascular disease, diabetes, or other health 
conditions to require pharmacologic intervention, and thus should be counted as part of 




Scores for each biomarker were summed to create an AL score for each 
participant. Because each biomarker can be scored as either 0 or 1, AL scores range from 
0 to 10.  
 
Determining attributes of AL in pregnant women 
To determine the attributes of AL in pregnant women, its characteristics in 
pregnant women were compared to those in non-pregnant women. Specifically, the 
association of AL with age, race, and SES were assessed. The two SES measures 
considered in this analysis were highest education level obtained and ratio of family 
income to poverty. These are among the few SES-related variables available in NHANES 
and were also used as measures of SES in several previous AL studies (Bird et al. 2010; 
Merkin et al. 2009; Kaestner et al. 2009; Seeman et al. 2008; Allsworth et al. 2005).  
Based on the results of previous research, it was hypothesized that pregnant  women with 
higher AL scores would be more likely to be older, to be non-Hispanic Black vs. non-
Hispanic White or Mexican American, to have lower income, and to have higher 
education levels compared with pregnant women with lower AL scores (Chyu & 
Upchurch, 2011; Seeman et al., 2008; Geronimus et al., 2006; Crimmins et al., 2003; 
Seeman et al., 1997). 
There are numerous ways to define high and low AL. Most studies determine the 
threshold(s) for categorizing AL scores based either on previous studies or on the 
distribution of AL scores in the study sample (Juster et al., 2010). Previous research has 
suggested that AL is associated with significant differences in morbidity and mortality 




1997). Kaestner et al. (2009) performed analyses using both 3 and 4 as the cutoff for high 
AL, and found similar results in their study population with either cutoff. In the current 
study, high AL was defined as a score greater than or equal to 4, and low AL as a score 
less than 4. For completeness, the data were also analyzed using a high/low cutoff of 3. 
Because having only two categories, high and low AL, is a relatively crude way to 
consider this construct, another analysis was performed with AL categorized into three 
groups: low (AL score of 0 to 1), moderate (AL score of 2 to 3), and high (AL score of 4 
or greater). This categorization is based on approximate tertiles of the distribution of the 
pregnant and non-pregnant NHANES samples. Several past studies have also categorized 




Because NHANES has a complex, non-random sampling design, the complex 
survey design procedures in SAS 9.2 were used for the statistical analysis. NHANES 
provides sample weights that account for non-response, stratification, and clustering 
(CDC, 2006). Variables to estimate variance estimation are also provided by NHANES 
for the primary sampling units (SDMVPSU) and strata (SDMVSTRA). Subsamples of 
NHANES data require special weighting; this study used the subsample weights included 
in the laboratory files. These subsample weights were combined for the four data cycles 





All NHANES data for this study, including demographic information and 
laboratory data, were downloaded from the NHANES website (CDC, 2011b). The data 
files from the four data cycles 1999-2006 were appended and merged, recoding variables 
as appropriate. 
For the first two research aims, which described the distribution of the ten AL-
related biomarkers, two-sample independent t-tests were used to compare the mean levels 
of each biomarker in the samples of pregnant and non-pregnant women and for women in 
early vs. late pregnancy. ANOVA was used to compare the mean levels of each 
biomarker in women in the 1st, 2nd, and 3rd trimesters of pregnancy. All tests performed in 
this study were two-sided and the alpha level was set to 0.05. Significant p values are 
designated with an asterisk in all tables and figures. 
Research aims 4 and 5 involved calculating and then comparing AL scores in 
different groups of women. Because AL is an ordinal variable and is not normally 
distributed, non-parametric tests were employed to compare the distributions in different 
groups. The Wilcoxon rank sum test was used to compare the distributions of AL scores 
in the samples of pregnant and non-pregnant women and for women in early vs. late 
pregnancy. The Kruskal-Wallis test was used to compare the distributions of AL scores in 
women in the 1st, 2nd, and 3rd trimesters of pregnancy. These tests are the non-parametric 
analogs of the independent two-sample t test and ANOVA, respectively. 
Three types of statistical analyses were performed as part of research aim 6, 
which determined the attributes of AL in pregnant women with regard to race, age, 
income, and education level. The first was a univariate analysis to determine the 




ANOVA tests were used, as appropriate, to compare the proportions of high and low AL 
separately by race, age, income, and education level. The second analysis was a 
multivariate logistic regression to examine the contribution of each demographic variable 
(race, age, income, and education level) as a predictor of high AL when each of the other 
variables was held constant. The third was a cluster analysis, a process used to discover 
natural groupings and identify underlying patterns in a data set (Frades & Matthieson, 
2010).  
The present study appears to be only the second study to analyze AL using cluster 
analysis. Von Thiele et al. (2006) used cluster analysis to group variables related to 
recovery from work stress, and then used those groupings to predict AL scores in a group 
of adult women. The current study is the first to attempt a cluster analysis to help 
describe the characteristics of AL in a population. 
The cluster analysis in this study employed the average linkage method to 
produce hierarchical clusters, which were then analyzed graphically in a dendrogram. 
The characteristics of the two resulting clusters were compared using independent two-
sample t-tests (mean age and ratio of family income to poverty), chi-square tests (race 
and education level), and a two-sided Wilcoxon two-sample test (AL score). SAS 9.2 
does not have a survey procedure for cluster analysis, so clusters were created and 
descriptive statistics calculated using the non-weighted observations. Because cluster 
analysis is an exploratory technique, this analysis still provided an overview of the 






Human subject protections 
All of the NHANES data used in study are de-identified and publicly available. 
People who choose to participate in the NHANES study give written informed consent, 
and NHANES data collection has been approved by an CDC institutional review board 
(CDC, 2006). The aims and methods of the current study were approved (as exempt) by 






Chapter 5: Results 
 
Research Aim 1: Assessing AL-related biomarkers in pregnant and non-pregnant women 
 
Demographic information 
There were significant differences in age, race, and marital status among pregnant 
and non-pregnant women in the NHANES sample (Table 3). Pregnant women were 
younger and more likely to be  married than non-pregnant women (p<0.01). This is to be 
expected, as a majority of children are born to younger, married women (Martin et al., 
2011). Pregnant women were less likely to be non-Hispanic White and more likely to be 
non-Hispanic Black or Mexican American than non-pregnant women (p<0.01). This is 
also not surprising, as the birth rate for non-Hispanic Black and Mexican American 
women is higher than that for non-Hispanic White women in the United States (Martin et 
al., 2011). There was no significant difference in education level or ratio of family 
income to poverty between the pregnant and non-pregnant women (p=0.16 for education, 





Table 3: Demographics of pregnant and non-pregnant women 
 Pregnant Non-pregnant P value 
N 1138 4993  
Mean age 27.39 30.57 <0.01* 
Race   <0.01* 
       Non-Hispanic White 56.43% 66.13%  
       Non-Hispanic Black 14.22% 12.55%  
       Mexican-American 16.14% 9.43%  
       Other 13.20% 11.89%  
Education   0.16 
       Less than high school 22.44% 23.60%  
       High school diploma 18.97% 22.98%  
       More than high school 58.58% 53.42%  
Marital status   <0.01* 
       Married 64.27% 44.90%  
       Widowed <1% <1%  
       Divorced <1% 7.28%  
       Separated 1.84% 3.80%  
       Never married 20.85% 35.45%  
       Living with partner 12.08% 8.57%  
Ratio of family income to poverty 2.62 2.74 0.21 
 
Distributions of AL-related biomarkers  
The mean levels of each of the ten AL-related biomarkers were significantly 
different among pregnant and non-pregnant women in the NHANES sample (p<0.01; 
Table 4). Further discussion of the levels of each biomarker in pregnant and non-pregnant 
women is included with the results of research aim 3.
 
  





Pregnant women Non-pregnant women 
 Mean (SE) Mean (SE) 25th centile 50th centile 75th centile 25th centile 50th centile 75th centile 
CRP 
(mg/dL) 
0.78 (0.06) 0.41 (0.02)* 0.25 0.49 0.91 0.05 0.17 0.45 
Albumin 
(g/dL) 
3.60 (0.02) 4.27 (0.01)* 3.21 3.55 3.88 4.01 4.23 4.44 
Total chol. 
(mg/dL) 
213.24 (2.65) 186.70 (0.73)* 171.76 209.59 244.51 160.09 182.81 207.85 
HDL chol. 
(mg/dL) 
64.38 (0.99) 55.70 (0.38)* 51.48 62.95 73.79 44.15 53.60 64.15 
Creatinine 
(umol/L) 
48.22 (0.79) 63.49 (0.27)* 35.54 43.83 53.03 53.03 60.12 70.71 
HbA1C 
(%) 
4.95 (0.02) 5.18 (0.01)* 4.68 4.89 5.10 4.88 5.07 5.26 
HCY 
(umol/dL) 
4.44 (0.06) 6.90 (0.06)* 3.48 4.22 5.07 5.50 6.46 7.65 
SBP  
(mm Hg) 
108.34 (0.62) 111.00 (0.23)* 101.28 107.72 113.68 103.09 109.27 117.32 
DBP 
(mm Hg) 
59.60 (0.62) 68.50 (0.27)* 53.26 59.31 66.22 61.59 67.95 74.43 
60-sec  
pulse 





Research Aim 2: AL-related biomarkers among pregnant women by stage of pregnancy 
 
Demographic information 
Based on the NHANES sample, there were no significant differences in mean age, 
race, marital status, education level, or ratio of family income to poverty in pregnant 
women in their 1st, 2nd, or 3rd trimesters, or in pregnant women in early vs. late pregnancy 
(p>0.05 for all; Tables 5 and 6). This result is as expected, as there is no social or 
biological reason to believe that women in different stages of pregnancy would differ in 
their demographic characteristics.  
 
Table 5: Demographics of pregnant women by trimester 
 1st trimester 2nd trimester 3rd trimester P value 
N 209 412 376  
Mean age 27.58 27.05 27.85 0.54 
Race    0.18 
       Non-Hispanic White 64.44% 56.62% 52.80%  
       Non-Hispanic Black 10.67% 14.95% 13.23%  
       Mexican-American 18.00% 16.26% 15.12%  
       Other 6.89% 12.17% 18.85%  
Education    0.18 
       Less than high school 26.59% 20.27% 15.44%  
       High school diploma 12.75% 22.13% 15.36%  
       More than high school 60.66% 57.60% 69.20%  
Marital status    0.69 
       Married 64.06% 65.37% 70.17%  
       Widowed <1% <1% <1%  
       Divorced <1% <1% <1%  
       Separated 1.39% 1.64% <1%  
       Never married 21.50% 21.50% 14.89%  
       Living with partner 12.47% 11.34% 14.89%  
Ratio of family income to 
poverty 





Table 6: Demographics of pregnant women by early vs. late pregnancy 
 Early 
pregnancy 
Late pregnancy P value 
N 349 648  
Mean age 27.72 27.31 0.58 
Race   0.16 
       Non-Hispanic White 60.39% 55.34%  
       Non-Hispanic Black 12.27% 13.84%  
       Mexican-American 18.49% 14.88%  
       Other 8.85% 15.94%  
Education   0.09 
       Less than high school 24.72% 17.27%  
       High school diploma 12.10% 20.91%  
       More than high school 63.18% 61.82%  
Marital status   0.29 
       Married 66.78% 66.61%  
       Widowed <1% <1%  
       Divorced <1% <1%  
       Separated 2.08% <1%  
       Never married 20.92% 18.04%  
       Living with partner 9.81% 13.93%  
Ratio of family income to poverty 2.55 2.72 0.36 
 
Distributions of AL-related biomarkers  
Levels of all but one of the AL-related biomarkers (albumin) were significantly 
different among women in different trimesters of pregnancy in the NHANES sample 
(p<0.05; Table 7). Levels of all but two of the AL-related biomarkers (albumin and 
systolic blood pressure) were significantly different in women in early vs. late pregnancy 
(p<0.05; Table 8). Further discussion of the levels of each biomarker in different stages 




Table 7: Means and quartiles of AL-related biomarkers in pregnant women by trimester 
Measure Means by trimester 1st trimester quartiles 
(N=209) 
2nd trimester quartiles 
(N=412) 











































































































Table 8: Means and quartiles of AL-related biomarkers in pregnant women by early vs. late pregnancy 
Measure Means for early and late pregnancy (SE) Early pregnancy (N=349) Late pregnancy (N=648) 
 Early  Late p value for 
means 











































































Research Aim 3: Establishing normal ranges for each AL-related biomarker 
The existence of clinically established reference ranges for each AL-related 
biomarker in healthy pregnant women suggests that each of the biomarkers changes by a 




Table 9: Clinically established reference ranges for AL-related biomarkers in pregnant women 
AL-related 
biomarker 
Expected change during pregnancy: 
Clinical reference materials 
Reference ranges in healthy pregnant women: Results of clinical studies 
 Expected change Source(s) Reference range Sample 
size 
Criteria for 








within the normal 




Serum CRP, mg/dL  
--Week 7-17: 0.32-11.91  
--Week 17-24: 0.40-14.02  
--Week 24-28: 0.43-20.28  
--Week 28-31: 0.43-36.97  
--Week 31-34: 0.33-11.92  
--Week 34-38: 0.64-28.26 
 
52 “Normal, spontaneous 
pregnancy at booking.” 
Excluded women 
taking drugs other than 
iron and folic acid. 




Begins to decline in 
early pregnancy, and 
decline continues 
throughout pregnancy. 
Decreases by 10-20% 
compared to pre-
pregnancy levels. 






& Lind, 1973 
Blood albumin, g/L 
--Week 7-17: 32.2-43.2 
--Week 17-24: 27.9-36.9 
--Week 24-28: 27.0-34.6 
--Week 28-31: 25.1-33.7 
--Week 31-34: 24.4-33.7 
--Week 34-38: 23.1-33.8 
 
52 “Normal, spontaneous 
pregnancy at booking.” 
Excluded women 
taking drugs other than 
iron and folic acid. 







First decreases, but 









& Lind, 1973 
Cholesterol, mg/dL 
--1st tri: 177.9 +/- 33.4 
(144.5-211.3) 
--2nd tri: 254.6 +/- 47.4 
(207.2-302.0) 
--3rd tri: 282.6 +/- 72.3 
(210.3-354.9) 
 
23 Normal course and 
outcome of pregnancy, 
not taking any 
medication known to 
interfere with lipid 
metabolism. 
 




Increases by 12 weeks 
of pregnancy and 
remains increased 
through the rest of 
pregnancy.  Maximum 
values at around 20 







--1st tri: 53.6 +/- 11.9 (41.7-
65.5) 
--2nd tri: 63.3 +/- 8.4 (54.9-
71.7) 
--3rd tri: 56.1 +/- 10.3 (45.8-
66.4) 
 
23 Normal course and 
outcome of pregnancy, 
not taking any 
medication known to 
interfere with lipid 
metabolism. 
 




Significantly lower in 
pregnant women 
compared to non-
pregnant women.   








Plasma creatinine, μmol/L 
--Week 7-17: 36-62 
--Week 17-24: 34-58 
--Week 24-28: 32-62 
--Week 28-31: 32-56 
--Week 31-34: 34-58 
--Week 34-38: 33-60 
 
52 “Normal, spontaneous 
pregnancy at booking.” 
Excluded women 
taking drugs other than 
iron and folic acid. 








pregnancy. Reaches its 
lowest point between 
23 and 26 weeks, then 




White, non-fasting HbA1C, 
% 
--1st tri: 4.6-5.6 
--2nd tri: 4.5-5.6 
--3rd tri: 4.5-6.1 
 
Asian, non-fasting HbA1C, 
%13 
--1st tri: 4.7-5.8 
--2nd tri: 4.7-5.7 










diabetes, any previous 











Decreases by about 
50% during 
pregnancy. Most of 
this decrease occurs in 
the first and second 
trimesters; 
homocysteine levels 




Plasma total homocysteine, 
μmol/L4 
--9 weeks: 5.50-16.12 
--16 weeks: 4.28-12.40 
--20 weeks: 4.25-12.64 
--24 weeks: 4.03-12.55 
--28 weeks: 3.93-12.06 
--32 weeks: 4.38-11.73 




healthy term babies. 
Velzing-










Total decrease in mean 
arterial pressure of 
about 10 mm Hg. 
Lowest level by 24th 
week, rises slowly 
through the rest of 
pregnancy. Decrease 
in blood pressure is 
almost entirely due to 
fall in diastolic BP. 
There is relatively 
little change in systolic 




Systolic, 5th-95th centile 
(Caucasians), mm Hg: 
--Weeks 6-13: 90-128 
--Weeks 14-25: 89-129 
--Weeks 26-42: 90-132 
 
Diastolic, 5th-95th centile 
(Caucasians), mm Hg: 
-- Weeks 6-13: 48-75 
-- Weeks 14-25: 48-74 
-- Weeks 26-42: 49-79 
 
 















increased in early 
pregnancy, reaches 
maximum in 3rd 
trimester. Ultimately 
rises by 15-20 BPM to 









24-hour heart rate, BPM 
--Early pregnancy: (< or = 6 
weeks gestation):  80 +/- 6 
(74-86) 
--Late pregnancy (9th 
month): 
 87 +/- 8 (79-95) 
 
20 Singleton pregnancies, 
nonsmoking, carried 
pregnancy to term 





Comparing levels of AL-related biomarkers in the NHANES samples with published 
reference ranges 
Overall, the mean values for each biomarker in the NHANES sample of pregnant 
women were consistent with published reference ranges. Comparing the data from Tables 
4, 7, and 8 with the expected changes and clinical reference ranges from Table 9, the 
following information can be reported for each Al-related biomarker: 
 
C-reactive protein: In the NHANES sample, the mean CRP levels were significantly 
different in pregnant and non-pregnant women (p<0.01), and as expected from clinical 
reference materials, CRP levels were higher in pregnant women (Gronowski, 2004). The 
mean CRP level in the NHANES sample of pregnant women, 0.78 mg/dL, fell within the 
reference range observed by Larsson et al. (2008). The mean CRP levels in women in the 
first, second, and third trimesters of pregnancy were not significantly different (p=0.69); 
nor were the mean levels in early vs. late pregnancy (p=0.17). However, the mean level 
for each trimester and for early vs. late pregnancy fell into the week-specific reference 
ranges reported by Larsson et al (2008).  
 
Albumin: In the NHANES sample, the mean albumin levels were significantly different 
in pregnant and non-pregnant women (p<0.01). As expected from clinical references, 
albumin levels were lower in pregnant women than in non-pregnant women (Gronowski, 
2004; Lockitch, 1993; Hytten & Lind, 1973). The mean albumin level in the NHANES 
sample of pregnant women, 3.60 g/dL, fell within the reference range observed by 




trimesters of pregnancy were significantly different (p<0.01), as were the levels in early 
vs. late pregnancy (p<0.01). The mean albumin level for each trimester and for early vs. 
late pregnancy fell into the week-specific reference ranges reported by Larsson et al. 
(2008).  
 
Total cholesterol: In the NHANES sample, the mean cholesterol levels were significantly 
different in pregnant and non-pregnant women (p<0.01). As expected from clinical 
references, the levels were higher in pregnant women than in non-pregnant women 
(Gronowski, 2004; Lockitch, 1993; Hytten & Lind, 1973). The mean total cholesterol 
level in the NHANES sample of pregnant women, 213.24 mg/dL, fell within the 
reference range observed by Belo et al. (2004). The mean total cholesterol levels in 
women in the first, second, and third trimesters of pregnancy were significantly different 
(p<0.01), as were the levels in early vs. late pregnancy (p<0.01). The mean total 
cholesterol level for each trimester fell into the trimester-specific reference ranges 
reported by Belo et al. (2004). 
 
HDL cholesterol: In the NHANES sample, the mean HDL cholesterol levels were 
significantly different in pregnant and non-pregnant women (p<0.01). As expected from 
clinical references, levels were higher in pregnant women than in non-pregnant women 
(Gronowski, 2004; Lockitch, 1993). The mean HDL cholesterol level in the NHANES 
sample of pregnant women, 64.38 mg/dL, fell within the reference range observed by 
Belo et al. (2004). The mean HDL cholesterol levels in women in the first, second, and 




early vs. late pregnancy (p<0.01). The mean HDL cholesterol level for the first and 
second trimesters fell into the trimester-specific reference ranges reported by Belo et al. 
(2004). The third-trimester mean in our sample, 67.61 mg/dL, was slightly higher than 
the upper value of the reference range reported by Belo et al. (2004) (66.4 mg/dL). 
 
Creatinine: In the NHANES sample, mean creatinine levels were significantly different 
in pregnant and non-pregnant women (p<0.01). As expected from clinical references, 
levels were lower in pregnant women than in non-pregnant women (Gronowski, 2004; 
Lockitch, 1993). The mean creatinine level in the NHANES sample of pregnant women, 
48.22 μmol/L, fell within the reference range observed by Larsson et al. (2008). The 
mean creatinine levels in women in the first, second, and third trimesters of pregnancy 
were significantly different (P<0.01), as were the levels in early vs. late pregnancy 
(p<0.01). The mean albumin level for each trimester and for early vs. late pregnancy fell 
into the week-specific reference ranges reported by Larsson et al. (2008). 
 
Hemoglobin A1C: In the NHANES sample, mean hemoglobin A1C levels were 
significantly different in pregnant and non-pregnant women (p<0.01). As expected from 
clinical references, levels were lower in pregnant women than in non-pregnant women 
(Gronowski, 2004). The mean hemoglobin A1C level in the NHANES sample of 
pregnant women, 4.95%, fell within the reference range observed by Hartland et al. 
(1999). The mean hemoglobin A1C levels in women in the first, second, and third 




vs. late pregnancy (p<0.01). The mean hemoglobin A1C level for each trimester fell into 
the trimester-specific reference ranges reported by Hartland et al. (1999). 
 
Homocysteine: In the NHANES sample, mean homocysteine levels were significantly 
different in pregnant and non-pregnant women (p<0.01). As expected from clinical 
reference materials, levels were lower in pregnant women than in non-pregnant women 
(Robinson, 2000). The mean homocysteine level in the NHANES sample of pregnant 
women, 4.44 μmol/dL, fell within the reference range observed by Velzing-Aarts et al. 
(2005). The mean homocysteine levels in women in the first, second, and third trimesters 
of pregnancy were significantly different (p<0.01), as were the levels in early vs. late 
pregnancy (p<0.01). The mean homocysteine level for each trimester fell into the 
trimester-specific reference ranges reported by Velzing-Aarts et al. (2005). 
 
Systolic and diastolic blood pressure: In the NHANES sample, mean SBP and DBP were 
significantly different in pregnant and non-pregnant women (p<0.01 for both). As 
expected from clinical reference materials, SBP and DBP levels were lower in pregnant 
women than in non-pregnant women (Chamberlain & Broughton-Pipkin, 1998). The 
mean SBP and DBP levels in the NHANES sample of pregnant women, 108.34 mm Hg 
and 59.60 mm Hg, respectively, fell within the reference ranges observed by Ochsenbein-
Kolble et al. (2004). The mean SBP and DBP levels in the first, second, and third 
trimesters of pregnancy were significantly different (p<0.01 for both). Mean DBP levels 




SBP levels were not (p=0.56). The mean SBP and DBP levels for each trimester fell into 
the trimester-specific reference ranges reported by Ochsenbein-Kolble et al. (2004). 
 
Heart rate: In the NHANES sample, mean heart rate was significantly different in 
pregnant and non-pregnant women (p<0.01). As expected from clinical reference 
materials, heart rate was higher in pregnant women than in non-pregnant women 
(Gronowski, 2004; Chamberlain & Broughton-Pipkin, 1998; Hytten & Lind, 1973). The 
mean heart rate in the NHANES sample of pregnant women, 85.76 beats per minute, fell 
within the reference range observed by Stein et al. (1999). The mean heart rate in the 
NHANES sample of women in the first, second, and third trimesters of pregnancy were 
significantly different (p<0.01), as were mean heart rates in early vs. late pregnancy 
(p<0.01). The mean heart rate for women in early and late pregnancy fell into the specific 
early and late pregnancy reference ranges reported by Stein et al. (1999). 
 
Research Aim 4: Comparing AL scores in pregnant and non-pregnant women 
Based in the NHANES sample, pregnant and non-pregnant women had very 
similar AL scores (Table 10). The median AL score was higher in pregnant women than 
in non-pregnant women, but the mean scores differed very little.  
 
Table 10: AL scores in pregnant and non-pregnant women 
 Median AL score Mean AL score Range 
Pregnant women 3 2.752 0-8.00 





The distributions of AL scores in pregnant and non-pregnant women appear very 
similar, although they are statistically different (p<0.01; Figure 1). This difference is 
probably due in large part to the sample sizes (>1000 in each group).  
 
Figure 1: Frequency of AL scores in pregnant and non-pregnant women 
 
 
Research Aim 5: Comparing AL scores among pregnant women in different stages of 
pregnancy 
Women in different trimesters of pregnancy had similar mean and median AL 
scores (Table 11), although there appeared to be more variability in mean AL scores 
compared to the previous analysis of all pregnant and non-pregnant women. This 
































Table 11: AL scores in pregnant women by trimester of pregnancy 
 Median AL score Mean AL score Range 
1st trimester 2 2.47 0-6.00 
2nd trimester 3 2.73 0-8.00 
3rd trimester 3 2.88 0-8.00 
 
The distributions of AL scores in the samples pregnant women by trimester have 
the same general shape, although they are statistically different (p<0.01; Figure 2).  
 
Figure 2: Frequency of AL scores in pregnant women by trimester of pregnancy 
 
 
When pregnant women were grouped into early vs. late pregnancy, they had the 























Frequency of AL scores in pregnant women by trimester of 










Table 12: AL scores in pregnant women by early vs. late pregnancy 
 Median AL 
score 
Mean AL score Range 
Early pregnancy 3 2.83 0-8.00 
Late pregnancy 3 2.80 0-8.00 
 
The distributions of AL scores in pregnant women by early vs. late pregnancy 
have a similar shape, and they are not statistically different (p=0.37; Figure 3). 
 
Figure 3: Frequency of AL scores in pregnant women by early vs. late pregnancy 
 
 
Research Aim 6: Determining attributes of AL in pregnant women 
This study categorized AL in several different ways to determine whether 
attributes of AL differ depending on how its levels are defined. In one analysis, high and 




















Frequency of AL scores in pregnant women by early vs. late 








In another analysis, high and low AL were defined using a cutoff AL score of 3. 
The results of this analysis were very similar to results when a cutoff score of 4 was used. 
Data for that analysis are included in Appendix 3. 
In third analysis, AL was categorized into three levels: high, medium, and low. 
The results of these analyses were similar to the results when AL was categorized only 
into high and low. These results are also included in Appendix 4. 
The remainder of this section presents the attributes of AL using a cutoff of 4 to 
categorize AL scores as high or low. For ease of interpretation, only the percentage of 
high AL is included in the figures in this section. The corresponding proportions of low 
AL in each group are (1 - % high AL). Full frequency tables for high and low AL by age, 
race, ratio of family income to poverty level, and education level are included in 
Appendix 5.  
Using an AL score of 4 as the cutoff to define low and high AL, approximately 
the same proportion of pregnant and non-pregnant women in the NHANES sample had 
low and high AL (p=0.68; Figure 4). 
 




















Race and AL 
Considering the frequencies of high and low AL by race, non-pregnant women of 
different races had significantly different AL (p<0.01), but the proportions of high and 
low AL did not differ significantly among pregnant women (p=0.12; Figure 5). 
 
Figure 5: Percentage of high AL in pregnant and non-pregnant women by race 
 
 
In both pregnant and non-pregnant women, non-Hispanic Black women had a 
higher percentage of high AL scores compared with non-Hispanic White women. 
Mexican American women had a lower percentage of high AL scores than either non-
Hispanic White or non-Hispanic Black women. However, these differences did not reach 
the level of statistical significance in the sample of pregnant women. 
From previous studies of race and AL, it was expected that non-Hispanic Black 
women would have higher AL scores than non-Hispanic White or Mexican American 















































pregnant women, the results also suggest that non-Hispanic Black women have higher 
AL than women in other race groups, although the lack of statistical significance allows 
no firm conclusions to be drawn. 
 
Age and AL 
Considering the frequencies of high and low AL by age, non-pregnant women in 
different age groups had significantly different AL (p<0.01), but the proportions of high 
and low AL did not differ significantly by age in pregnant women (p=0.85; Figure 6). 
 
Figure 6: Percentage of high AL in pregnant and non-pregnant women by age 
 
 
In non-pregnant women, the percentage of high AL increased in each age group, 
as expected from previous studies that showed a direct correlation between AL score and 


















































group. Although pregnant women in the oldest age group (35-44) had a higher percentage 
of AL than women in the other age groups, the difference was not statistically significant. 
When age was considered as a continuous variable instead of a categorical 
variable, results were similar. The mean age among pregnant women with high AL was 
not significantly different from the mean age among those with low AL (p=0.10). Among 
non-pregnant women, those with high AL were older than those with low AL (p<0.01). 
These data are available in Appendix 5. 
 
Race, age, and AL 
Geronimus et al. (2006) found that AL increases more quickly in Black women 
than in White women, suggesting that race may be an effect modifier of the relationship 
between age and AL—this is the basis of the weathering hypothesis. To determine 
whether the effect of age on AL was different in women of different races in this study, 





Figure 7: Percentage of high AL in pregnant and non-pregnant women by race and age 
 
 
Figure 7 clearly shows that, in non-pregnant women, the percentage of high AL 
differed significantly by age in all race groups (p<0.01). AL increases in each age group 
for all races, and in every age group, non-Hispanic Black women have higher percentages 
of AL than women of other races. These findings are consistent with previous studies of 














































































































sample, the percentage of high AL did not differ significantly by age in any race group, 
and there was no clear trend of increasing AL with age in women of any race. 
 
Income and AL 
This study considered ratio of family income to poverty as an indicator of income 
level. This ratio ranged from 0 to 5, with higher scores indicating higher levels of income. 
Among the sample of non-pregnant women, percentage of high AL differed significantly 
by income level (p=0.02). However, there was no significant difference in the sample of 
pregnant women (p=0.93; Figure 8). 
 
Figure 8: Percentage of high AL in pregnant and non-pregnant women by ratio of family 
income to poverty level 
 
 
The proportion of non-pregnant women with high AL appeared to decrease with 







































Percentage of high AL in pregnant and non-pregnant women by ratio of 









inversely correlated with income. Among pregnant women, however, income did not 
appear to have an effect on AL. 
When ratio of family income to poverty level was considered as a continuous 
variable instead of a categorical variable, results were similar. The mean ratio among 
pregnant women with high AL was not significantly different than the mean ratio among 
those with low AL (p=0.57). Among non-pregnant women, women with high AL had a 
lower mean ratio than women with low AL (p<0.01). These data are available in 
Appendix 5. 
 
Education level and AL 
The percentage of high AL differed significantly among pregnant women 
(p=0.04) but not among non-pregnant women (p=0.07) in the NHANES sample (Figure 
9). 
 





































Percentage of high AL in pregnant and non-pregnant women by level 
of education 
Less than high school
High school or equivalent




From previous studies, AL would have been expected to be higher among women 
of lower educational attainment. Although the percentage of high AL differed 
significantly by education level in pregnant women, these results did not show the 
expected pattern of decreasing AL with increasing education. Surprisingly, the expected 
pattern was not seen in the sample of non-pregnant women, either.  
One possible explanation for this finding is that the women included in this study 
are females as young as age 15, so some participants have a high school or less than high 
school level of education simply because of their age. To assess this possibility, the 
analysis was repeated, restricting the age range to 22-44 years (Figure 10). 
 
Figure 10: Percentage of high AL in pregnant and non-pregnant women by level of 
education, ages 22-44 only 
 
 
When the youngest women are excluded from the sample, the difference in 
percentage of high AL becomes statistically significant in non-pregnant women (p<0.01), 






































Percentage of high AL in pregnant and non-pregnant women by level of 
education, ages 22-44 only 
Less than high school
High school or equivalent




levels of education. However, although the differences are also significant in the non-
pregnant sample (p=0.02), the data still do not suggest that increasing levels of education 
are associated with lower AL. In fact, the pregnant women with the highest level of 
education (more than high school) also had the highest percentage of high AL. 
All other analyses in this study were done with the full sample of pregnant and 
non-pregnant women (ages 15-44) because restricting the age range to 22-44 years 
decreased the sample size by 24% in the sample of pregnant women and 42% in the 
sample of non-pregnant women. This reduction would reduce power in the other 
analyses. Additionally, age is an important consideration in the study of AL, and 
comparisons between women at the youngest ages with those at older ages are of interest 
in the remainder of this study. 
 
Logistic regression modeling 
To consider all of the demographic variables together, a logistic regression model 
was created with AL category (high/low defined using a cutoff AL score of 4) as the 
response variable and age, race, ratio of family income to poverty level, and education 
level as predictor variables. The results of modeling the probability of having high AL in 





Table 13: Logistic regression model: Race, age, income, and education level as 
predictors of high AL in pregnant women 
Parameter Type 3 analysis 
of effects 
Analysis of maximum likelihood 
estimates 
Odds ratio estimates 
 Wald 
χ2  
Pr> χ2 Estimate 
(SE) 







-- -- -0.21 (0.36) 0.35 0.55 -- -- 
        
Race 
 
4.39 0.22 -- -- -- -- -- 
NH White -- -- Reference -- -- -- -- 
NH Black -- -- -0.22 (0.35) 0.41 0.52 0.80 0.41, 1.58 
MA -- -- -0.74 (0.36) 4.32 0.04* 0.48 0.24, 0.96 
Other -- -- -0.45 (0.46) 0.95 0.33 0.64 0.26, 1.58 
        
Age 
 
5.23 0.26 -- -- -- -- -- 
15-19 -- -- Reference -- -- -- -- 
20-24 -- -- -0.51 (0.40) 1.66 0.20 0.60 0.28, 1.31 
25-29 -- -- -0.70 (0.45) 2.45 0.12 0.50 0.21, 1.19 
30-34 -- -- -0.51 (0.52) 0.99 0.32 0.60 0.22, 1.65 
35-44 -- --  0.08 (0.46) 0.03 0.86 1.09 0.44, 2.67 
        
Income 
(ratio I/P) 
2.56 0.63 -- -- -- -- -- 
0-1.00 -- -- Reference -- -- -- -- 
1.01-2.00 -- --  0.30 (0.50) 0.35 0.55 1.35 0.50, 3.61 
2.01-3.00 -- -- -0.64 (0.47) 1.87 0.17 0.53 0.21, 1.32 
3.01-4.00 -- -- -0.21 (0.48) 0.19 0.66 0.81 0.32, 2.06 
4.01-5.00 -- -- -0.19 (0.32) 0.33 0.56 0.83 0.44, 1.56 
        
Education 
 
7.99 0.02* -- -- -- -- -- 
< HS -- -- Reference -- -- -- -- 
HS or eq. -- -- -0.49 (0.37) 1.76 0.18 0.62 0.30, 1.26 






Table 14: Logistic regression model: Race, age, income, and education level as 
predictors of high AL in non-pregnant women 
Parameter Type 3 analysis 
of effects 
Analysis of maximum likelihood 
estimates 
Odds ratio estimates 
 Wald 
χ2  
Pr> χ2 Estimate 
(SE) 







-- -- -1.61 (0.18) 77.66 <0.01* -- -- 
        
Race 
 
63.70 <.0001* -- -- -- -- -- 
NH White -- -- Reference -- -- -- -- 
NH Black -- --  0.76 (0.12) 39.56 <0.01* 2.14 1.69, 2.72 
MA -- -- -0.25 (0.18) 2.01 0.16 0.78 0.55, 1.10 
Other -- -- -0.30 (0.22) 1.88 0.17 0.74 0.48, 1.14 
        
Age 
 
87.65 <.0001* -- -- -- -- -- 
15-19 -- -- Reference -- -- -- -- 
20-24 -- --  0.01 (0.21) 0.002 0.96 1.01 0.67, 1.53 
25-29 -- --  0.95 (0.19) 25.34 <0.01* 2.59 1.79, 3.75 
30-34 -- --  1.15 (0.21) 30.58 <0.01* 3.17 2.11, 4.77 
35-44 -- --  1.66 (0.19) 75.77 <0.01* 5.26 3.62, 7.64 
        
Income 
(ratio I/P) 
22.97 0.0001* -- -- -- -- -- 
0-1.00 -- -- Reference -- -- -- -- 
1.01-2.00 -- -- -0.30 (0.15) 4.26 0.04* 0.74 0.56, 0.99 
2.01-3.00 -- -- -0.36 (0.19) 3.37 0.07 0.70 0.48, 1.02 
3.01-4.00 -- -- -0.59 (0.17) 11.57 <0.01* 0.55 0.39, 0.78 
4.01-5.00 -- -- -0.64 (0.14) 21.11 <0.01* 0.52 0.40, 0.69 
        
Education 
 
1.67 0.43 -- -- -- -- -- 
< HS -- -- Reference -- -- -- -- 
HS or eq. -- --  0.05 (0.15) 0.12 0.72 1.05 0.79, 1.40 






The type 3 analysis of effects in the NHANES sample of pregnant women 
suggests that of the four predictor variables in the model, only education level had a 
statistically significant relationship with the response variable, high/low AL (p=0.02). In 
the sample of non-pregnant women, the results were reversed: of the predictor variables 
in the model, all but education were statistically significantly associated with high/low 
AL (all p<0.01). 
Results from the levels of each predictor variable in the model are presented 
below. 
Race: In the sample of pregnant women, Mexican American women had smaller 
odds of having high AL compared with non-Hispanic White women (OR=0.48, 95% 
CI=0.03, 0.86) when the other variables were held constant. The odds of having high AL 
was not statistically different between non-Hispanic Black women or women of other 
races and non-Hispanic White women (Figure 11). 
In the sample of non-pregnant women, non-Hispanic Black women had greater 
odds of having high AL compared with non-Hispanic White women (OR=2.14, 95% 
CI=1.69-2.72) when the other variables are held constant. The odds of having high AL 
was not statistically different between Mexican American women or women of other 










Age: In pregnant women, the odds of having high AL were not statistically 
associated with age in any age group (Figure 12). In non-pregnant women, the odds of 
having high AL increased with age starting with the 25-29 year-old age group (Age 25-
29: OR=2.59, 95% CI=1.79, 3.75) when the other variables were held constant. By age 
30-34, the odds of having high AL were more than three times the odds for 15-19 year-
olds (OR=3.17, 95% CI=2.11, 4.77), and the odds in 35-44 year-olds were more than five 
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Income: In the sample of pregnant women, ratio of family income to poverty was 
not associated with the odds of having high AL in any income category (Figure 13). 
Among non-pregnant women, the odds of having high AL decreased with increasing 
income when the other variables were held constant. Women with the highest level of 
family income, 4.01 to 5.00 times the poverty level, are about half as likely to have high 
AL as those with the lowest level of family income, 0 to 1.00 times the poverty level 
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Figure 13: Odds ratios and 95% confidence intervals of high AL by income in pregnant 
and non-pregnant women 
 
 
Education: Education level was not associated with the odds of having high AL in 
for any level of education in either pregnant or non-pregnant women, when all other 
variables were held constant. This finding may be explained by the inclusion of high-
school and college-age women in the samples, as discussed in the univariate analysis 
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Figure 14: Odds ratios and 95% confidence intervals of high AL by education level in 




A cluster analysis of the variables for AL score, race, age, ratio of family income 
to poverty, and education level in the sample of pregnant women yielded the dendrogram 
in Figure 15. This dendrogram suggests two major clusters of pregnant women based on 
these variables. Compared to the women in cluster 2, the women in cluster 1 are older, 
have higher incomes, are more likely to be white, and have higher levels of education 
(p<0.01 for all; Table 15). However, the median AL scores were not statistically different 
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Figure 15: Dendrogram illustrating clusters of AL score, age, race, income, and 
education level in pregnant women 
 
 
Table 15: Characteristics of clusters with regard to AL score, age, race, income, and 
education level in pregnant women 
 Cluster 1 Cluster 2 P value 
Number of observations 317 427  




(SD=3.24, range 15-28) 
<0.01*  
Race   <0.01*  
     NH White 58.68% (186) 35.60% (152)  
     NH Black 8.20%   (26) 20.10%   (86)  
     Mexican American 20.82% (66) 33.96% (145)  
     Other 12.30% (39) 10.30% (44)  
Education level   <0.01*  
     Less than HS 13.56% (43) 44.73% (191)  
     HS or equivalent 14.51% (46) 25.76% (110)  
     More than HS 71.92% (228) 29.51% (126)  
Ratio of income to poverty Mean=3.32  
(SD=1.65, range 0-5) 
Mean=1.68 
(SD=1.35, range 0-5) 
<0.01*  










Chapter 6: Discussion 
 
AL-related biomarkers in pregnant and non-pregnant women 
The mean levels of each of the ten AL-related biomarkers differed significantly in 
the NHANES samples of pregnant and non-pregnant women. This result is not surprising, 
as most studies of AL exclude pregnant women because the levels of various biomarkers 
are assumed to change during pregnancy. However, there were other notable differences 
between the pregnant and non-pregnant women. The difference in mean age in the two 
groups is of particular interest. The mean age in the two groups differed by more than 3 
years (27.39 years in pregnant women vs. 30.57 years in non-pregnant women, p<0.01). 
The age distributions in the two groups also look very different, with the highest 
percentage of pregnant women in the 25-29 age group and the highest percentage of non-
pregnant women in the 35-44 age group (Appendix 6). 
Because age is known to be associated with AL, the different age distributions in 
the two populations may have influenced the calculation of AL scores and interpretation 
of results in this study. Therefore, it could be informative to age-standardize the samples 
of pregnant and non-pregnant women. However, direct age standardization (the method 
recommended by NHANES) does not provide estimates of variance or weighted 
quartiles, which are necessary for calculating AL scores. Therefore, indirect age 
standardization would be necessary, and this approach would require recalculating the 
NHANES survey weights based on the birth rates for each age and race group. This 
approach is not recommended by NHANES; CDC researchers are currently working to 




communication). Once these weights are available, the analyses in the current study could 
be performed again to see whether age-standardization provides a more accurate picture 
of the characteristics of AL in pregnant women. 
Age-standardization is not an issue when comparing women in different stages of 
pregnancy, as mean ages did not differ by trimester (p=0.54) or in early vs. late 
pregnancy (p=0.58). Additionally, no significant differences were found in race, 
education, marital status, or income in women in different stages of pregnancy. However, 
mean the levels of most AL-related biomarkers were different in different stages of 
pregnancy, confirming that these biomarkers are not static during pregnancy. This finding 
suggests that it may be more informative to consider AL by stage of pregnancy than to 
lump all pregnant women together in a single group. Some AL-related biomarkers are 
known to increase or decrease throughout the course of pregnancy, whereas others 
fluctuate (e.g. blood pressure, which decreases during the second trimester but increases 
again during the third trimester [Chamberlain & Broughton-Pipkin, 1998]). Considering 
the levels of each biomarker by stage of pregnancy makes these patterns more apparent.  
 
Normal ranges for AL-related biomarkers in pregnant women 
The fact that normal reference ranges for the various biomarkers have been 
reported suggests that these levels change in predictable ways. Information from clinical 
reference materials and studies of healthy pregnant women indicate that levels of each 
biomarker change in similar ways in most pregnant women. The findings from the 
present study support that conclusion, as overall the mean values for each of the 10 AL-




published reference ranges and clinical reference materials. Levels of each biomarker 
measured by trimester and in early vs. late pregnancy were also in line with reference 
ranges reported by week or by trimester.  
Limitations of this approach included the questionable representativeness of the 
samples from which the reference ranges were calculated. The age, race, and other 
characteristics of the women included in each study were often not reported, and some 
reference ranges were calculated using only White women. Additionally, the reference 
range studies used different criteria for determining healthy pregnancies, and not all of 
them included a normal pregnancy outcome among their criteria. 
The measurements of mean biomarker levels presented in Tables 4, 7, and 8 may 
have clinical utility independent of their usefulness as building blocks of an AL index in 
pregnant women. Although reference ranges were available from the literature for each 
biomarker, few of these studies have been conducted and some are more than a decade 
old. The availability of mean levels and distributions of these biomarkers in a nationally 
representative sample of pregnant women could be of use to laboratories and OB/GYN 
practitioners who seek to interpret lab results as part of patient care. 
 
Comparing AL scores in pregnant and non-pregnant women and during different stages 
of pregnancy 
Initial analysis of AL scores in pregnant and non-pregnant women suggested that 
the mean and distribution of AL in the two groups is very similar. Like non-pregnant 
women, most pregnant women have an AL score of 1, 2, or 3, and very few have scores 




pregnant and non-pregnant women. However, the median AL scores in the two groups 
were different (3 in pregnant women vs. 2 in non-pregnant women), and the difference in 
the distribution of AL in the two groups was statistically significant (p<0.01). The 
significant difference may be a result of the large sample size of the two groups. 
When AL was considered by stage of pregnancy, the means and distributions of 
AL were also quite similar. When the sample of pregnant women was split into early 
pregnancy (less than 5 months) and late pregnancy (5+ months), the two groups had the 
same median AL score and very close mean AL scores. The distribution of AL in the 
groups was not statistically different (p=0.37). However, when the sample of pregnant 
women was split into trimesters, the median AL scores were different in the 1st trimester 
compared to the 2nd and 3rd trimesters (2 in the 1st trimester vs. 3 in the later trimesters), 
and the distributions of AL in the three groups were significantly different (p<0.01). 
These findings suggest that it may be more precise to consider AL by trimester of 
pregnancy instead of analyzing all pregnant women as a single group. However, size of 
the NHANES sample of pregnant women in each trimester is smaller than considering all 
pregnant women together, which would reduce the power of a trimester-based analysis.  
 
Attributes of AL in pregnant women 
The main objective of this study was to determine whether AL has similar 
attributes in pregnant women as it does in non-pregnant women. Based on the results of 
the univariate and multivariate analyses, it does not appear that AL has the same 
attributes in pregnant women with regard to race, age, income, and education. In the 




high AL in women of different races, age groups, or income levels (p>0.05 for all). Thus, 
when AL is measured this way, weathering as defined by Geronimus et al. (2006) is not 
seen in pregnant women. The only significant difference in the percentage of high AL in 
the sample of pregnant women was seen with education levels, and the results showed the 
opposite of what would have been expected: instead of being inversely correlated, 
pregnant women with the highest levels of education also had the highest AL (p=0.02). 
Because this study is the first to attempt to measure AL in pregnant women, an 
exploratory cluster analysis was undertaken to identify whether AL scores clustered with 
variables for race, age, income, and education level in the NHANES sample of pregnant 
women. The cluster analysis suggested two major groupings within the sample of 
pregnant women. Compared with cluster 2, the women in cluster 1 were older, more 
likely to be non-Hispanic White, more likely to have greater than a high school level of 
education, and more likely to have higher income (p<0.01 for all). However, the median 
AL score did not differ significantly between the two clusters (p=0.12). These results 
were consistent with those of the univariate and multivariate logistic regression analyses, 
underscoring the finding that AL is not clearly associated with race, age, income, or 
education level in the NHANES sample of pregnant women. 
The results of this study did not appear to be sensitive to the way in which AL 
was categorized. Results were similar whether AL was defined as high and low with a 
cutoff score of 3, as high and low with a cutoff score of 4, or with three levels (high, 
moderate, and low). These results underscore the finding of Kaestner et al. (2009) that it 




The sample of non-pregnant women was analyzed as a way to internally validate 
the measurement of AL in this study. Levels of AL showed expected patterns with regard 
to age, race, income, and education (when the age was restricted to 22-44 year-old 
women) compared to previous studies (Chyu & Upchurch, 2011; Seeman et al., 2008; 
Geronimus et al., 2006; Crimmins et al., 2003; Seeman et al., 1997). Specifically, non-
pregnant women with high AL were more likely to be non-Hispanic Black, to be older, to 
have lower income, and to have lower levels of education (p<0.01 for all). That the 
results in non-pregnant women were consistent with those of previous studies suggests 





Chapter 7: Conclusions 
 
AL does not appear to have the same attributes in pregnant women as it does in 
non-pregnant women, although there are  a few intriguing similarities. These similarities, 
as well as the potential explanations for the differences seen between the two groups, 
warrant future study. 
There are several reasons why AL may not show similar patterns in pregnant 
women compared to non-pregnant women. One of the primary reasons may be related to 
the different age distributions of the pregnant and non-pregnant women, as discussed 
above. Another potential reason is that there may be chronic stress in younger pregnant 
women that is not experienced by their non-pregnant peers. According to the National 
Campaign to Prevent Teen and Unplanned Pregnancy (2009), teenagers who become 
pregnant tend to be more socioeconomically disadvantaged than non-pregnant women of 
the same age. Teenage mothers are more likely to be from single-parent families, have a 
family income below 200% of the federal poverty level, and to have a history of 
childhood sexual or physical abuse. Chronic stress beginning at younger ages may help 
explain why AL was not correlated with age in the pregnant women in this study. 
Although the differences were not statistically significant, the results of the logistic 
regression model suggested that pregnant women in the 20-24, 25-29, and 30-34 year-old 
age groups may have lower AL than pregnant women in the 15-19 year-old age group. It 
is possible that social factors related to teenage pregnancy contribute to chronic stress in 
the youngest pregnant women, which would help explain why AL has different attributes 




Other reasons for the differences between AL in pregnant women and in non-
pregnant women may involve the methodologies used to study AL in the two groups. 
First, it is possible that AL must be measured in a different way to be meaningful in 
pregnant women. For example, the ten biomarkers available in NHANES may not be 
appropriate to measure this construct in this population. Other factors, such as certain 
hormones, might be the proper biomarkers to assess AL in pregnant women. Alternately, 
it may be informative to split the existing biomarkers into categories (e.g. cardiovascular, 
immune, and metabolic, as suggested by Seeman et al. [2008]). One or more of these 
subsets of biomarkers may be more useful than all ten for measuring AL in pregnant 
women. It is also possible that AL is meaningful to measure in pregnant women, but only 
when pregnancy is considered by trimester or by early vs. late pregnancy. Because the 
various biomarkers do not remain static during pregnancy, important attributes of AL 
could be obscured if all pregnant women are lumped together into a single group. Lastly, 
it remains a possibility that AL is not meaningful to measure in pregnancy. However, 
further research is necessary before this conclusion can be drawn. 
 
Strengths and limitations 
The strengths of this study include the use of a nationally representative sample of 
pregnant and non-pregnant women from continuous NHANES. Pregnant women were 
oversampled from 1999 through 2006, so the study included a relatively large sample of 
pregnant women (Mirel et al., 2009). This study also conservatively identified pregnant 
and non-pregnant women using several reproductive health variables to minimize 




construction of a robust AL index and provided the necessary demographic and health 
history data for each participant. 
Several limitations of this study are related to the nature of data available from 
NHANES. NHANES is a cross-sectional study, so the data could not be used to evaluate 
changes in AL over the life course or assess the relationship between AL during 
pregnancy and subsequent birth outcomes. Only a subset of biomarkers that might be 
relevant to AL were available in the NHANES data set; for example, no primary markers 
of AL such as catecholamines or cortisol are included. This study relied on questionnaire 
responses regarding medication use and demographic characteristics, so it was subject to 
the inherent limitations of self-reported data. 
Another limitation of the study is the possibility of unmeasured confounders. 
Because this study was a preliminary look at AL in pregnant women, the logistic 
regression model included only race, age, education, and income. Future studies may also 
wish to include possible confounding variables such as cigarette smoking, alcohol and 
drug use, and dietary factors. Other reproductive factors, such as parity and history of 
adverse birth outcomes might also be relevant. Data on these variables are available in 





Chapter 8: Future Directions 
 
The results of the current study raise several interesting questions about AL and 
pregnancy that could be addressed in future analyses. These include: 
• Does age-standardization of the samples of pregnant and non-pregnant women 
change the distribution of AL scores in these groups, and does it affect the 
attributes of AL with regard to race, age, income, and education? 
• Does analyzing AL in pregnant women based on stage of pregnancy, particularly 
by trimester, give a more precise picture of AL than considering all pregnant 
women as a single group?  
• If younger pregnant women experience more chronic stress than their non-
pregnant peers, and thus have different patterns of AL compared to non-pregnant 
women, does restricting the analysis to older women (i.e. 22 to 44 years) yield 
different results? Additionally, it might be interesting to compare the attributes of 
AL in the youngest group of pregnant women to those of the oldest group of 
pregnant women to determine whether there is support for the hypothesis that 
younger pregnant women have higher levels of AL due to more chronic stress 
compared with their non-pregnant counterparts. 
• Does using a different set of AL-related biomarkers, or splitting the existing set of 
biomarkers into immune, cardiovascular, and metabolic categories, provide a 





If further research is able determine an accurate and useful way to measure AL during 
pregnancy, future studies could be undertaken to see whether levels of AL can identify 
high-risk pregnancies and/or predict adverse birth outcomes. As a first step, it would be 
interesting to link the data for pregnant women in the NHANES data set with state birth 
certificate records to determine birth outcomes for each pregnancy. This data linkage 
would open up a wealth of research opportunities into risk factors for birth outcomes, 
including AL.  
This project represents the first foray into studying AL during pregnancy. Although 
the results yielded few conclusions about the meaningfulness of AL in pregnant women, 
they suggest that there are both interesting similarities and major differences in the 
attributes of AL in pregnant and non-pregnant women. Exploring these similarities and 
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Appendix 2: Distributions of AL scores in pregnant and non-pregnant women, NHANES 
1999-2006 
 
The following tables present the frequency, weighted percentage, and standard 
error of the percentage for each AL score (0-10) in different groups. * indicates the result 
is significant at p<0.05.  
 
AL scores in pregnant and non-pregnant women 











0 85 7.09 (1.17) 520 8.89 (0.62) 
1 209 16.74 (1.85) 1044 19.13 (0.68) 
2 272 23.52 (2.28) 1146 22.67 (0.81) 
3 240 21.18 (2.15) 925 18.87 (0.75) 
4 176 15.85 (1.72) 608 13.27 (0.6) 
5 97 10.76 (1.62) 374 8.03 (0.53) 
6 41 3.40 (0.89) 222 5.17 (0.38) 
7 15 1.33 (0.59) 109 2.62 (0.29) 
8 3 0.13 (0.07) 37 1.04 (0.2) 
9 0 0 5 0.18 (0.09) 
10 0 0 3 0.13 (0.07) 
Totals: 1138 100% 4993 100% 





AL scores in pregnant women by trimester 















0 29 15.97 (5.67) 32 6.82 (1.93) 20 3.49 (1.06) 
1 52 19.32 (4.87) 65 16.20 (3.53) 69 18.95 (3.88) 
2 53 18.42 (3.76) 98 21.76 (3.39) 88 18.74 (3.33) 
3 33 17.83 (3.19) 98 25.25 (3.75) 84 29.78 (4.58) 
4 23 10.31 (2.71) 69 20.00 (3.12) 58 11.83 (2.39) 
5 14 12.92 (3.93) 32 4.73 (0.95) 34 10.01 (3.26) 
6 5 5.23 (3.09) 12 4.01 (1.80) 17 5.76 (1.90) 
7 0 0 4 0.44 (0.25) 5 1.30 (0.77) 
8 0 0 2 0.79 (0.66) 1 0.14 (0.14) 
9 0 0 0 0 0 0 
10 0 0 0 0 0 0 
Totals: 209 100% 412 100% 376 100% 






AL scores in pregnant women by early vs. late pregnancy 











0 25 9.30 (1.68) 45 4.94 (1.26) 
1 60 16.26 (3.80) 115 19.14 (3.04) 
2 92 19.40 (3.31) 139 21.02 (3.38) 
3 69 22.02 (3.37) 145 21.83 (2.88) 
4 58 13.67 (2.61) 112 19.46 (3.17) 
5 30 11.48 (2.42) 47 7.48 (2.23) 
6 11 5.64 (1.58) 34 4.74 (1.31) 
7 3 2.07 (1.75) 10 1.31 (0.56) 
8 1 0.16 (0.16) 1 0.08 (0.08) 
9 0 0 0 0 
10 0 0 0 0 
Totals: 349 100% 648 100% 





Appendix 3: Attributes of AL categorized as high/low using a cutoff AL score of 3 
 
The following tables present the frequency of high and low AL by race, age, 
income, and education level. In these analyses, high and low AL were defined using a 
cutoff AL score of 3. Low AL was defined as a score less than 3; high AL was defined as 
a score greater than or equal to 3.  
All counts are number of women in sample; all percentages are weighted using 
NHANES weights to reflect the U.S. population. * indicates the result is significant at 
p<0.05. 
 
Frequency of high and low AL in pregnant and non-pregnant women 
 Pregnant women Non-pregnant women 
High AL 47.36%     (566) 50.68%     (2710) 
Low AL 52.64%     (572) 49.32%     (2283) 
Totals 100%        (1138) 100%        (4993) 
 Rao-Scott chi-square = 1.39  p=0.24 
 










Low AL 48.49% (246) 44.61% (65) 55.62% (197) 35.39% (58) 47.36% (566) 
High AL 51.51% (259) 55.39% (106) 44.39% (143) 64.61% (64) 52.64% (572) 
Totals 100%    (505) 100%    (171) 100%    (340) 100%    (122) 100%   (1138) 


































Totals 100%     
(1893) 
100%   
(1250) 
 100%  
(1409) 
100%    
(441) 
100%    
(4993) 
 Rao-Scott chi-square: 91.11  p<.0001* 
 
AL category by age category in pregnant women 
 15-19 20-24 25-29 30-34 35-44 Totals 




































 Rao-Scott chi-square: 0.68  p=0.95 
 
AL category by age category in non-pregnant women 
 15-19 20-24 25-29 30-34 35-44 Totals 










50.68%     
(2710) 





























AL category by mean age (continuous) in pregnant women 
 Mean age SE N 
Low AL 27.35 0.43 566 
High AL 27.42 0.48 572 
Totals 27.39 0.32 1138 
ANOVA:  F=0.04   p=0.85 
 
AL category by mean age (continuous) in non-pregnant women 
 Mean age SE N 
Low AL 28.56 0.23 2710 
High AL 32.64 0.22 2883 
Totals 30.57 0.17 4993 
ANOVA:  F=287.66  p<.0001* 
 
Age and AL, stratified by race in pregnant women 












































Rao-Scott chi-square = 0.34  p=0.99 



























































































Rao-Scott chi-square = 3.86  p=0.43 
 
Age and AL, stratified by race in non-pregnant women 












































Rao-Scott chi-square = 69.48  p<.0001* 












































Rao-Scott chi-square = 66.74  p<.0001* 
















































Ratio of family income to poverty (categorical) by AL category in pregnant women 
 <1 1-2 2-3 3-4 4-5 Totals 




































Rao-Scott chi-square = 2.07  p=0.72 
 
Ratio of family income to poverty (categorical) by AL category in non-pregnant women 
 <1 1-2 2-3 3-4 4-5 Totals 




































Rao-Scott chi-square = 7.08  p=0.13 
 
Ratio of family income to poverty by AL category in pregnant women 
 Mean ratio of 
income/poverty 
SE N 
Low AL 2.69 0.13 522 
High AL 2.55 0.14 544 
Totals 2.62 0.10 1066 






Ratio of family income to poverty by AL category in non-pregnant women 
 Mean ratio of 
income/poverty 
SE N 
Low AL 2.81 0.06 2521 
High AL 2.66 0.05 2156 
Totals 2.74 0.05 4677 
 ANOVA: F=10.48   p=0.0012* 
 
AL category by education level in pregnant women 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL 39.52% (128) 62.68% (101) 49.66% (191) 48.87% (420) 
High AL 60.48% (127) 37.24% (72) 50.34% (180) 50.13% (379) 
Totals 100%    (255) 100%    (173) 100%    (371) 100%    (799) 
Rao-Scott chi-square: 6.38  p=0.04* 
 
AL category by education level in non-pregnant women 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL 55.12% (940) 47.19% (387) 53.21% (708) 52.28% (2035) 
High AL 44.88% (587) 52.81% (368) 46.79% (665) 47.72% (1620) 
Totals 100%    (1527) 100%    (755) 100%    (1373) 100%    (3655) 





Appendix 4: Attributes of AL categorized into three levels (high/moderate/low) 
 
The following tables present the frequency of high, moderate, and low AL by 
race, age, income, and education level. In these analyses, three categories of AL were 
defined as follows:  Low AL was defined as a score of 0 or 1; moderate AL was defined 
as a score of 2 or 3; and high AL was defined as a score of 4 or greater. 
All counts are number of women in sample; all percentages are weighted using 
NHANES weights to reflect the U.S. population. * indicates the result is significant at 
p<0.05. 
 
Frequency of high, moderate, and low AL in pregnant and non-pregnant women 
 Pregnant women Non-pregnant women 
Low AL 23.84%   (294) 28.02%   (1564) 
Moderate AL 44.70%   (512) 41.54%   (2071) 
High AL 31.47%   (332) 30.44%   (1358) 
Totals 100%      (1138) 100%      (4993) 















Low AL 26.72%   
(134) 
18.14%   (29) 29.61%    
(101) 
10.61%    
(30) 




39.96%   
(208) 
42.82%   (74) 47.16%    
(167) 
63.94%    
(63) 
44.70%   
(512) 
High AL 33.32%   
(163) 
40.04%   (68) 22.23%    
(72) 
25.45%    
(29) 
31.47%   
(332) 
Totals 100%      
(505) 
100%      
(171) 
100%       
(340) 
100%       
(122) 
100%      
(1138) 
Rao-Scott chi-square: 21.56  p=0.0015* 
 










Low AL 27.62%  
(559) 
18.44%    
(269) 
34.44%   
(572) 








34.66%    
(504) 
39.48%   
(557) 




High AL 28.99%  
(503) 
46.91%    
(477) 
26.08%   
(280) 




Totals 100%     
(1893) 
100%      
(1250) 
100%      
(1409) 
100%       
(441) 
100%      
(4993) 






AL category by age category in pregnant women 
 15-19 20-24 25-29 30-34 35-44 Totals 




28.24%   
(93) 
21.88%    
(70) 










41.73%   
(149) 
47.99%   
(126) 








30.03%   
(101) 
30.13%    
(64) 




Totals 100%      
(159) 
100%     
(237) 
100%      
(343) 
100%      
(260) 
100%     
(139) 
100%    
(1138) 
 Rao-Scott chi-square: 3.51  p=0.90 
 
AL category by age category in non-pregnant women 
 15-19 20-24 25-29 30-34 35-44 Totals 






































Totals 100%    
(1880) 
100%    
(507) 
100%    
(534) 
100%    
(584) 
100%    
(1488) 
100%     
(4993) 
 Rao-Scott chi-square: 184.41  p<.0001* 
 
AL category by mean age (continuous) in pregnant women 
 Mean age SE N 
Low AL 27.03 0.40 294 
Moderate AL 27.27 0.48 512 
High AL 27.81 0.66 332 






AL category by mean age (continuous) in non-pregnant women 
 Mean age SE N 
Low AL 27.93 0.31 1564 
Moderate AL 29.86 0.32 2071 
High AL 33.96 0.27 1358 
ANOVA:  F = 337.34  p<.0001* 
 
Age and AL, stratified by race in pregnant women 


























































 Rao-Scott chi-square = 3.09  p=0.92 

























































































































Rao-Scott chi-square = 14.58  p=0.07 
 
Age and AL, stratified by race in non-pregnant women 


























































 Rao-Scott chi-square: 92.71  p<.0001* 

























































































































 Rao-Scott chi-square: 78.36  p<.0001* 
 
Ratio of family income to poverty (categorical) by AL category in pregnant women 
 <1 1-2 2-3 3-4 4-5 Totals 
















































Rao-Scott chi-square = 8.16  p=0.42 
 
Ratio of family income to poverty (categorical) by AL category in non-pregnant women 
 <1 1-2 2-3 3-4 4-5 Totals 





















































Ratio of family income to poverty by AL category in pregnant women 
 Mean ratio of 
income/poverty 
SE N 
Low AL 2.81 0.17 268 
Moderate AL 2.49 0.14 476 
High AL 2.66 0.16 322 
 ANOVA  F=0.72   p=0.40 
 
Ratio of family income to poverty by AL category in non-pregnant women 
 Mean ratio of 
income/poverty 
SE N 
Low AL 2.77 0.09 1347 
Moderate AL 2.82 0.06 1953 
High AL 2.59 0.05 1287 
 ANOVA  F=9.63   p=.002* 
 
AL category by education level in pregnant women 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL  22.81%      (70) 39.08%      (61) 23.88%     (103) 26.23%      (234) 
Moderate AL 50.15%      (112) 41.73%      (69) 42.94%     (170) 44.33%      (351) 
High AL 27.05%      (73) 19.19%      (43) 33.68%     (98) 29.44%      (214) 
Totals 100%         (255) 100%         (173) 100%        (371) 100%         (799)  






AL category by education level in non-pregnant women 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL  30.79%      (556) 25.56%       (211) 28.84%     (408) 28.54%   (1175) 
Moderate AL 42.38%      (644) 40.38%       (303) 42.29%     (556) 41.87%   (1503) 
High AL 26.84%      (327) 34.06%       (241) 28.88%     (409) 29.59%   (977) 
Totals 100%       (1527) 100%          (755) 100%       (1373) 100%      (3655) 





Appendix 5: Attributes of AL categorized as high/low using a cutoff AL score of 4 
 
The following tables present the frequency of high and low AL by race, age, 
income, and education level. In these analyses, high and low AL were defined using a 
cutoff AL score of 4. Low AL was defined as a score less than 4; high AL was defined as 
a score greater than or equal to 4. 
All counts are number of women in sample; all percentages are weighted using 
NHANES weights to reflect the U.S. population. * indicates the result is significant at 
p<0.05. 
 
Frequency of high and low AL in pregnant and non-pregnant women 
 Pregnant women Non-pregnant women 
Low AL 68.53%     (806) 69.56%     (3635) 
High AL 31.47%     (332) 30.44%     (1358) 
Totals 100%        (1138) 100%        (4993) 
 Rao-Scott chi-square = 0.17  p=0.68 
 


















68.53%     
(806) 








31.47%     
(332) 
Totals 100%     
(505) 
100%     
(171) 
100%     
(340) 
100%   
(122) 
100%      
(1138) 


































Totals 100%    
(1893) 
100%    
(1250) 
 100%  
(1409) 
100%     
(441) 
100%    
(4993) 
 Rao-Scott chi-square: 71.77  p<.0001* 
 
AL category by age category in pregnant women 
 15-19 20-24 25-29 30-34 35-44 Totals 










68.53%     
(806) 
























 Rao-Scott chi-square: 1.34  p=0.85 
 
AL category by age category in non-pregnant women 
 15-19 20-24 25-29 30-34 35-44 Totals 










69.56%     
(3635) 





























AL category by mean age (continuous) in pregnant women 
 Mean age SE N 
Low AL 27.19 0.35 806 
High AL 27.82 0.66 332 
Totals 27.39 0.32 1138 
ANOVA:  F=2.78   p=0.10 
 
AL category by mean age (continuous) in non-pregnant women 
 Mean age SE N 
Low AL 29.09 0.24 3635 
High AL 33.96 0.27 1358 
Totals 30.57 0.17 4993 
ANOVA:  F=352.08  p<.0001* 
 
Age and AL, stratified by race in pregnant women 












































Rao-Scott chi-square = 1.87  p=0.76 




























































































Rao-Scott chi-square = 1.43  p=0.84 
  
Age and AL, stratified by race in non-pregnant women 












































Rao-Scott chi-square = 81.26  p<.0001* 












































Rao-Scott chi-square = 62.86  p<.0001* 
















































Ratio of family income to poverty (categorical) by AL category in pregnant women 
 <1 1-2 2-3 3-4 4-5 Totals 




































Rao-Scott chi-square = 0.83  p=0.93 
 
Ratio of family income to poverty (categorical) by AL category in non-pregnant women 
 <1 1-2 2-3 3-4 4-5 Totals 




































Rao-Scott chi-square = 11.53  p=0.02* 
 
Ratio of family income to poverty by AL category in pregnant women 
 Mean ratio of 
income/poverty 
SE N 
Low AL 2.60 0.11 744 
High AL 2.66 0.16 322 
Totals 2.62 0.10 1066 








Ratio of family income to poverty by AL category in non-pregnant women 
 Mean ratio of 
income/poverty 
SE N 
Low AL 2.80 0.05 3390 
High AL 2.59 0.05 1287 
Totals 2.74 0.05 4677 
ANOVA: F=18.42   p=<.0001* 
 
AL category by education level in pregnant women 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL 72.96% (182) 80.81% (130) 66.32% (273) 70.56% (585) 
High AL 27.04% (73) 19.89% (43) 33.68% (98) 29.44% (214) 
Totals 100%    (255) 100%    (173) 100%    (371) 100%    (799) 
Rao-Scott chi-square: 6.45  p=0.04* 
 
AL category by education level in non-pregnant women 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL 73.16% (1200) 65.94% (514) 71.12% (964) 70.41% (2678) 
High AL 26.84% (327) 34.06% (241) 28.88% (409) 29.59% (977) 
Totals 100%    (1527) 100%    (755) 100%    (1373) 100%    (3655) 
Rao-Scott chi-square: 5.45  p=0.07 
 
AL category by education level in pregnant women, age restricted to 22-44 years  
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL 77.28% (107) 81.20% (89) 64.79% (254) 69.61% (450) 
High AL 22.72% (35) 18.80% (30) 35.21% (92) 30.39% (157) 
Totals 100%    (142) 100%    (119) 100%    (346) 100% (607) 




AL category by education level in non-pregnant women, age restricted to 22-44 years 
 Less than high 
school 
High school or 
equivalent 
More than high 
school 
Totals 
Low AL 60.58% (327) 61.81% (281) 69.29% (750) 66.12% (1358) 
High AL 39.42% (200) 38.19% (202) 30.71% (374) 33.88% (776) 
Totals 100%    (527) 100%    (483) 100%    (1124) 100%    (2134) 
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